Subcutaneous immunoglobulin replacement therapy: ensuring success

M Elizabeth M Younger¹, William Blouin, Carla Duff, Kristin Buehler Epland, Elyse Murphy, Debra Sedlak

Affiliations

Affiliation

¹ Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Younger); Miami Children's Hospital, Miami, Florida (Mr Blouin); University of South Florida/All Children's Hospital, St. Petersburg, Florida (Ms Duff); Midwest Immunology Clinic, Plymouth, Minnesota (Ms Epland); and CSL Behring, King of Prussia, Pennsylvania (Ms Murphy); and Duke University Medical Center, Durham, North Carolina (Ms Sedlak). M. Elizabeth M. Younger, PhD, CRNP, is an assistant professor of pediatrics and a pediatric nurse practitioner in the Division of Pediatric Immunology at Johns Hopkins University School of Medicine in Baltimore, Maryland. She has extensive experience with managing immunoglobulin therapy for antibody-deficient patients. William Blouin, MSN, ARNP, CPNP, works in pediatric allergy and immunology at Miami Children's Hospital, Miami, Florida. With more than 35 years of experience in pediatrics, his interests and expertise are allergy, human immunodeficiency virus, immunology, infusion, and transplantation. Carla Duff, MSN, CPNP, CCRP, is a nurse practitioner in pediatric allergy and immunology at the University of South Florida/All Children's Hospital, St. Petersburg, Florida. She has many years of experience with clinical immunology and managing immunoglobulin replacement therapy for primary immunodeficiency patients. Kristin Buehler Epland, MSN, FNP, is a family nurse practitioner specializing in the care and diagnosis of primary immunodeficiencies and autoimmune diseases at Midwest Immunology Clinic, Plymouth, Minnesota. She has worked with immunodeficient patients through home and clinic infusion nursing. Elyse Murphy, BSN, RN, is a medical science liaison with CSL Behring in King of Prussia, Pennsylvania, and has more than 30 years of expertise in immunoglobulin therapies in immunology, hematology-oncology, neurology, and transplant therapeutic areas. Debra Sedlak, CPNP, has more than 30 years of experience in clinical immunology in the Division of Pediatric A

PMID: 25545976
DOI: 10.1097/NAN.0000000000000087

Review

Subcutaneous immunoglobulin replacement therapy: ensuring success

M Elizabeth M Younger et al. J Infus Nurs. 2015 Jan-Feb.

. 2015 Jan-Feb;38(1):70-9.

doi: 10.1097/NAN.0000000000000087.

Authors

M Elizabeth M Younger¹, William Blouin, Carla Duff, Kristin Buehler Epland, Elyse Murphy, Debra Sedlak

Affiliation

¹ Johns Hopkins University School of Medicine, Baltimore, Maryland (Dr Younger); Miami Children's Hospital, Miami, Florida (Mr Blouin); University of South Florida/All Children's Hospital, St. Petersburg, Florida (Ms Duff); Midwest Immunology Clinic, Plymouth, Minnesota (Ms Epland); and CSL Behring, King of Prussia, Pennsylvania (Ms Murphy); and Duke University Medical Center, Durham, North Carolina (Ms Sedlak). M. Elizabeth M. Younger, PhD, CRNP, is an assistant professor of pediatrics and a pediatric nurse practitioner in the Division of Pediatric Immunology at Johns Hopkins University School of Medicine in Baltimore, Maryland. She has extensive experience with managing immunoglobulin therapy for antibody-deficient patients. William Blouin, MSN, ARNP, CPNP, works in pediatric allergy and immunology at Miami Children's Hospital, Miami, Florida. With more than 35 years of experience in pediatrics, his interests and expertise are allergy, human immunodeficiency virus, immunology, infusion, and transplantation. Carla Duff, MSN, CPNP, CCRP, is a nurse practitioner in pediatric allergy and immunology at the University of South Florida/All Children's Hospital, St. Petersburg, Florida. She has many years of experience with clinical immunology and managing immunoglobulin replacement therapy for primary immunodeficiency patients. Kristin Buehler Epland, MSN, FNP, is a family nurse practitioner specializing in the care and diagnosis of primary immunodeficiencies and autoimmune diseases at Midwest Immunology Clinic, Plymouth, Minnesota. She has worked with immunodeficient patients through home and clinic infusion nursing. Elyse Murphy, BSN, RN, is a medical science liaison with CSL Behring in King of Prussia, Pennsylvania, and has more than 30 years of expertise in immunoglobulin therapies in immunology, hematology-oncology, neurology, and transplant therapeutic areas. Debra Sedlak, CPNP, has more than 30 years of experience in clinical immunology in the Division of Pediatric A

PMID: 25545976
DOI: 10.1097/NAN.0000000000000087

Abstract

Subcutaneous immunoglobulin (SCIg) infusions are an option for patients requiring immunoglobulin therapy. Nurses are uniquely positioned to advocate for patients and to teach them how to successfully manage their infusions. The purpose of this review is to describe SCIg therapy and to provide teaching instructions as well as creative tips to ensure treatment success.

PubMed Disclaimer

Comment in

A Missed Opportunity.
Rozen L, Duff K, Taggart C, Scott J. Rozen L, et al. J Infus Nurs. 2015 Jul-Aug;38(4):252-3. doi: 10.1097/NAN.0000000000000115. J Infus Nurs. 2015. PMID: 26126137 No abstract available.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Subcutaneous immunoglobulin replacement therapy: ensuring success

Affiliation

Subcutaneous immunoglobulin replacement therapy: ensuring success

Authors

Affiliation

Abstract

Comment in

Publication types

MeSH terms